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RESEARCH ARTICLE
The loss-of-function disease-mutation 
G301R in the  Na+/K+-ATPase α2 isoform 
decreases lesion volume and improves 
functional outcome after acute spinal cord 
injury in mice
Ditte Gry Ellman1, Toke Jost Isaksen2,4, Minna Christiansen Lund1, Safinaz Dursun1, Martin Wirenfeldt5,6, 
Louise Helskov Jørgensen5,6, Karin Lykke‑Hartmann2,3,4,7*  and Kate Lykke Lambertsen1,8,9*
Abstract 
Background: The  Na+/K+‑ATPases are transmembrane ion pumps important for maintenance of ion gradients across 
the plasma membrane that serve to support multiple cellular functions, such as membrane potentials, regulation of 
cellular volume and pH, and co‑transport of signaling transmitters in all animal cells. The α2Na
+/K+‑ATPase subunit 
isoform is predominantly expressed in astrocytes, which us the sharp  Na+‑gradient maintained by the sodium pump 
necessary for astroglial metabolism. Prolonged ischemia induces an elevation of  [Na+]i, decreased ATP levels and 
intracellular pH owing to anaerobic metabolism and lactate accumulation. During ischemia,  Na+/K+‑ATPase‑related 
functions will naturally increase the energy demand of the  Na+/K+‑ATPase ion pump. However, the role of the α2Na
+/
K+‑ATPase in contusion injury to the spinal cord remains unknown. We used mice heterozygous mice for the loss‑
of‑function disease‑mutation G301R in the Atp1a2 gene (α2
+/G301R) to study the effect of reduced α2Na
+/K+‑ATPase 
expression in a moderate contusion spinal cord injury (SCI) model.
Results: We found that α2
+/G301R mice display significantly improved functional recovery and decreased lesion volume 
compared to littermate controls (α2
+/+) 7 days after SCI. The protein level of the α1 isoform was significantly increased, 
in contrast to the α3 isoform that significantly decreased 3 days after SCI in both α2
+/G301R and α2
+/+ mice. The level of 
the α2 isoform was significantly decreased in α2
+/G301R mice both under naïve conditions and 3 days after SCI com‑
pared to α2
+/+ mice. We found no differences in astroglial aquaporin 4 levels and no changes in the expression of 
chemokines (CCL2, CCL5 and CXCL1) and cytokines (TNF, IL‑6, IL‑1β, IL‑10 and IL‑5) between genotypes, just as no 
apparent differences were observed in location and activation of CD45 and F4/80 positive microglia and infiltrating 
leukocytes.
Conclusion: Our proof of concept study demonstrates that reduced expression of the α2 isoform in the spinal cord 
is protective following SCI. Importantly, the BMS and lesion volume were assessed at 7 days after SCI, and longer time 
points after SCI were not evaluated. However, the α2 isoform is a potential possible target of therapeutic strategies for 
the treatment of SCI.
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Background
Spinal cord injury (SCI) results in massive cell loss at the 
site of the lesion. Injury to the central nervous system 
(CNS) causes a range of cellular and molecular changes 
that make changes to the local environment and impede 
regeneration. Cytokines and chemokines are released at 
the lesion site serving to recruit peripheral leukocytes 
to the injury site [1]. Astrocytes are the most numerous 
cells in the CNS and become reactive in response to neu-
ronal injury.
In the intact spinal cord there is limited proliferation of 
astrocytes. However, in response to injury, inflammatory 
cytokines cause adult astrocytes to proliferate and give 
rise to reactive astrocytes [2, 3].
Astrocytes are important for maintaining homeostasis 
within the CNS including regulating ion concentrations, 
neurotransmitter levels, pH and water homeostasis, 
support of the blood–brain barrier, regulating synap-
tic formation and function, and neuronal support. After 
neuronal activity, astrocytes are essential for clearing 
extracellular  K+ and regulating synaptic concentrations 
of the neurotransmitter glutamate. This is accomplished 
through the  Na+-dependent glutamate transporters 
EAAT1 and EAAT2 [4]. The uptake of glutamate via glu-
tamate transporters is forwarded by the  Na+-gradient. 
Astrocytes, therefore, rely on  Na+/K+-adenosine 
triphosphatase  (Na+/K+-ATPase) to pump out accumu-
lated intracellular  Na+ and import extracellular  K+  and 
thereby, the  Na+/K+-ATPase ion pump maintains the 
 Na+/K+ gradient essential for all cells [5, 6].
The  Na+/K+-ATPase-maintained electrochemical 
gradients of  Na+ and  K+ across the plasma membrane 
are prerequisites for electrical excitability and second-
ary transport. The minimum constellation of an active 
pump consists of an alpha (α) and a beta (β) subu-
nit [7, 8]. The α subunit is responsible for the catalytic 
and pharmacological properties [9], whereas the β and 
optional γ subunits may have regulatory functions 
[10–12]. Different isoforms combine to form kineti-
cally distinct complexes in different cells and tissues 
[13, 14]. In mammals, four distinct α isoforms (α1–α4) 
have been identified. The α1 subunit isoform is ubiq-
uitously expressed, the α2 is expressed in the brain, 
heart and skeleton muscles, the α3 isoform is expressed 
in the brain and heart, while the α4 subunit isoform is 
expressed exclusively in testis [15, 16]. In the adult 
brain, the α2 isoform is primarily expressed in astro-
cytes (alongside the α1 isoform), where it is coupled to 
various transporters (glutamate transporters and  Na+/
Ca2+ exchanger) [17–19]. Specifically, the α2 isoform is 
essential for clearance of extracellular  K+ and glutamate 
released into the synaptic cleft [18, 20–22].
Prolonged ischemia induces an elevation of  [Na+]i, 
increasing the energy demand of  Na+/K+ ATPase, rever-
sal of the  Na+/glutamate co-transporter, cell swelling and 
activates volume regulatory processes [23]. The  Na+/K+ 
ATPase activity (along with energy production processes) 
alongside passive  K+ uptake mechanisms are upregu-
lated in gliotic tissue located outside a spinal cord lesion 
to enhance such homeostatic mechanisms [24]. Interest-
ingly, a recent study showed that remote ischemic post-
conditioning could attenuate focal cerebral ischemia/
reperfusion injury, and the neuroprotective mechanism 
was related with the down-regulation of aquaporin 4 
(AQP4) in astrocytes [25]. Moreover, AQP4 knock out 
mice demonstrate significantly reduced cerebral edema 
and improved neurological outcome following ischemic 
stroke [26].
Increasing evidence points towards the  Na+/K+-
ATPase in regulating signaling pathways, such as the 
membrane-associated non-receptor tyrosine kinase 
Src, activation of Ras/Raf/ERK1/2, phosphate inositol 
3-kinase  (PI3K),  PI3K-dependent protein kinase B, phos-
pholipase C,  [Ca2+]i oscillations [27–29], and gene tran-
scription (Egr-1, Fos, June, Nr4a2, Hes1 and Gabre) [30].
Interestingly, increasing the  Ca2+ concentration can 
modulate transcription in two ways; (1) by promoting 
translocation of nuclear factor-kappa B (NF-κB) from the 
cytosol to the nucleus, and (2) by phosphorylating the 
cAMP response element binding protein (CREB) [31].
To explore the role of the α2 isoform following con-
tusion injury to the spinal cord, we took advantage of a 
newly generated knock-in mouse model harboring the 
Familial Hemiplegic migraine type 2 (FHM2) disease-
related loss of function mutation G301R in the Atp1a2 
gene [22]. Heterozygous mice (α2+/G301R) display patho-
logical relevant symptoms related to Familial Hemiplegic 
migraine type 2 (FHM2), and showed impaired gluta-
mate uptake in in  vitro-matured hippocampal mixed 
astrocyte-neuron cultures from α2G301R/G301R E17 embry-
onic mice [22]. Moreover, NMDA-type glutamate recep-
tor antagonists or progestin-only treatments reverted 
specific α2(+/G301R) behavioral phenotypes [22]. Mice 
homozygous for the G301R mutation (α2G301R/G301R) die 
immediately after birth [22]. In this study, SCI was per-
formed on heterozygous α2+/G301R mice to elaborate on 
the role of the α2Na+/K+-ATPase after SCI. We demon-
strate that α2+/G301R mice display significantly improved 
functional recovery and decreased lesion volume com-
pared to littermate controls (α2+/+) already 7  days after 
SCI. Although long-term evaluations after SCI were not 
assessed, however, this study, suggests that decreasing 
the level of the α2 isoform might serve as a new potential 
therapeutic target in SCI treatment.
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Results
Spinal cord of α2
+/G301R mice have reduced level of the α2 
isoform
Previously, it was shown that the G301 mutation con-
fers haploinsuffiency in heterozygous α2+/G301R mice with 
reduced levels of the α2 isoform in various brain struc-
tures [22]. To investigate the α2 isoform levels in the spi-
nal cord under naïve conditions, Western blotting was 
performed. As expected, α1 and α3 isoform levels were 
comparable between α2+/G301R and α2+/+ mice, whereas 
α2 isoform levels were reduced approximately 40% in α2+/
G301R mice compared to littermates (Fig.  1a, b; Table  1). 
The morphology of the naïve spinal cord tissue was 
assessed by immunofluorescent detection of the α2 iso-
form and the neuronal marker Neuronal Nuclei (NeuN) 
and counterstained with Hoechst, and revealed no gross 
morphological differences between the α2+/G301R and α2+/+ 
mice under naïve conditions (Fig.  1c, shown for a α2+/
G301R mouse only). In both α2+/G301R and α2+/+ mice, the α2 
isoform was preferentially detected in the white matter, 
both the posterior, lateral and anterior funiculi, with little 
astrocytic-localized α2 isoform in the grey matter.
α2
+/G301R mice display improved functional outcome 
and decreased lesion volume 7 days after SCI
To date, the role of the  Na+/K+-ATPase in SCI has not 
been addressed despite its essential role in astroglial func-
tions. To examine the role of the astrocytic α2 isoform, 
we performed SCI on the α2+/G301R mice and compared 
the effect to α2+/+ mice after 7 days in order to assess any 
correlations. The α2+/G301R and α2+/+ mice were subjected 
to SCI and subsequently allowed 7  days post-surgical 
survival. The α2+/G301R mice significantly improved their 
BMS score compared to α2+/+ mice (Fig. 2a), demonstrat-
ing that reducing the levels of the α2Na+/K+-ATPase in 
the spinal cord improved functional outcome after SCI 
in acute experiments (7  days post SCI). To evaluate the 
injury site, luxol fast blue (LFB) and glial fibrillary acidic 
protein (GFAP)/Nissl/DAPI staining was performed. 
Both analysis of LFB and GFAP/Nissl/DAPI stained sec-
tions revealed significantly reduced lesion volumes in 
α2+/G301R mice compared to α2+/+ mice 7  days after SCI 
(Fig. 2b–d).
Reduced α2 isoform levels after spinal cord injury  
in α2
+/G301R mice
In order to investigate whether the protein level of the 
α2 isoform was altered following SCI, Western blotting 
was performed on tissue from both naïve and SCI mice. 
Moreover, the protein levels of the two other CNS-
expressed  Na+/K+-ATPase α subunit isoforms, α1 and α3, 
were included (Fig.  3a). The α1 levels were significantly 
increased in both α2+/+ and α2+/G301R mice 3  days after 
SCI compared to naïve conditions, with no difference 
between genotypes (Fig.  3b). In contrast, α2 levels were 
Fig. 1 α2 isoform levels are reduced in α2
+/G301R compared to α2
+/+ mice under naïve conditions. a Western blotting analysis showed comparable 
levels of α1 and α3, but reduced levels of α2 protein in the spinal cord of α2
+/G301R compared to α2
+/+ mice under naïve conditions. b Quantification of 
α1, α2 and α3 isoform levels compared to GAPDH levels (Tukey’s multiple comparisons test; n.s (p = 0.99) for α1, **p < 0.01 (p = 0.0028) for α2 and n.s 
p = 0.99) for α3 (n = 4 mice/group). c Immunofluorescent staining of α2 (green) in a thoracic spinal cord section from naïve α2+/G301R mice co‑stained 
with the neuronal marker NeuN (red, arrows). Scale bar 50 μm
Table 1 Quantification of  α1, α2, and  α3 isoform levels 
in the spinal cord in naïve conditions
Data are presented as mean ± SEM, n = 4/group. Data are normalized to GAPDH 
protein
α1 α2 α3
α2
+/+ 1.00 ± 0.08 1.00 ± 0.05 1.00 ± 0.15
α2
+/G301R 1.01 ± 0.06 0.59 ± 0.02 0.97 ± 0.09
Page 4 of 13Ellman et al. BMC Neurosci  (2017) 18:66 
significantly decreased only in α2+/+ mice 3  days after 
SCI compared to naïve conditions, whereas no change 
was observed in α2 levels in the α2+/G301R mice (Fig.  3c). 
Both under naïve conditions and 3 days after SCI, α3 lev-
els were significantly decreased in α2+/G301R compared to 
α2+/+ mice. The α3 levels were found to be significantly 
decreased after SCI compared to naïve conditions in both 
α2+/+ and α2+/G301R mice, however no difference between 
the two genotypes was observed (Fig. 3d).
Aquaporin 4 protein levels were comparable between  
α2
+/G301R and α2
+/+ mice
We next examined if levels of AQP4 was altered follow-
ing SCI, in line with previous studies on cerebral edema 
[25, 26]. We performed Western blotting and immuno-
histochemistry on tissue from both naïve and SCI mice. 
The AQP4 levels were not significantly altered between 
genotypes, α2+/+ and α2+/G301R mice, nor were the level 
significantly different between naïve conditions and 
Fig. 2 α2
+/G301R mice display decreased lesion size and improved functional recovery 7 days after SCI. a Functional outcome determined by BMS 
score in the open field test after SCI was significantly improved in α2
+/G301R compared to α2
+/+ mice 7 days after SCI (two‑way RM ANOVA: time 
****p < 0.0001  F3,42 = 467; genotype *p < 0.05  F1,14 = 8.67; time:genotype **p < 0.01  F3,42 = 6.49, Bonferroni post hoc ****p < 0.0001, n = 7–9 mice/
group). b Lesion volume was significantly decreased in α2
+/G301R compared to α2
+/+ mice 7 days after SCI when analyzing luxol fast blue (LFB) stained 
sections (student’s t test, *p < 0.05, n = 6–8 mice/group). c Representative LFB stained thoracic spinal cord sections from α2+/+ and α2+/G301R mice 
allowed 7 days survival after SCI. d Lesion volume was significantly decreased in α2
+/G301R compared to α2
+/+ mice 7 days after SCI when analyzing 
GFAP/Nissl/DAPI stainings (student’s t test, *p < 0.05, n = 6–8 mice/group). e Representative GFAP/Nissl/DAPI stained thoracic spinal cord sections 
from α2
+/+ and α2
+/G301R mice allowed 7 days survival after SCI. Results are expressed as mean ± SEM. Scale bar 200 μm
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SCI-treated animals (Fig.  4a, b; Table  2). Immunohis-
tochemistry on spinal cord sections demonstrated that 
SCI induced loss of AQP4 staining within the lesion area 
and that the gross morphology of the AQP4 staining was 
comparable between α2+/+ and α2+/G301R mice (Fig. 4c).
In summary, the levels of AQP4 protein were reduced 
after SCI, but no difference was observed between α2+/+ 
and α2+/G301R mice after 7 days. Moreover, no differences 
in the overall gross distribution of AQP4 in spinal cord 
sections was not observed.
Chemokine levels were comparable between α2
+/G301R 
and α2
+/+ mice
In order to investigate whether changes in lesion size 
could be a consequence of changes in the inflammatory 
environment within the lesioned cord, multiplex analy-
sis was used to investigate changes in chemokines. We 
found that CXCL1 (Fig.  5a), CCL2 (Fig.  5b), and CCL5 
(Fig.  5c) protein levels were significantly upregulated in 
the lesioned spinal cord of α2+/G301R and α2+/+ mice com-
pared to naïve conditions; however, we observed no dif-
ferences between the two genotypes at this time point.
The inflammatory response was comparable between  
α2
+/G301R and α2
+/+ mice 3 days after SCI
Using multiplex analysis, potential changes in cytokine 
expression were examined. We found that TNF (Fig. 6a), 
IL-6 (Fig.  6b) and IL-10 (Fig.  6c) were all significantly 
upregulated in the lesioned cord of α2+/G301R and α2+/+ 
mice 3  days after SCI compared to naïve conditions, 
but no differences between genotypes were observed. 
In contrast, IL-1β was only significantly upregulated in 
α2+/+ mice 3 days after SCI compared to naïve conditions 
(Fig. 6d). No change was observed in IL-5 levels (Fig. 6e).
Microglial/leukocyte activation is comparable between  
α2
+/G301R and α2
+/+ mice 7 days after SCI
Macrophages can respond to endogenous stimuli that 
are rapidly generated following injury or infection [32]. 
These early stimuli can exert a marked (usually transient) 
effect on the physiology of macrophages. The response of 
macrophages to e.g. tissue damage can predict how these 
cells will respond during an adaptive immune response. 
We used the EGF-like module-containing mucin-like 
hormone receptor-like 1 (F4/80) glycoprotein and the 
Fig. 3 Changes in α1, α2, and α3 protein levels after SCI. a α1, α2, and α3 isoform levels in naïve conditions and 3 days after SCI were evaluated in 
spinal cord lysates from α2
+/+ and α2
+/G301R mice by Western blot analysis. Data are normalized to β‑actin protein expression. Representative experi‑
ments are shown. b–d Western blot quantification showed a significant increase in α1 isoform levels 3 days after SCI, with no difference between 
genotypes (two‑way ANOVA: time ****p < 0.0001,  F1,12 = 35.06, **p < 0.01) (b), a significant decrease in α2 isoform levels 3 days after SCI, with signifi‑
cantly reduced levels in α2
+/G301R compared to α2
+/+ mice (two‑way ANOVA: time ***p < 0.001,  F1,20 = 16.88; genotype ****p < 0.0001,  F1,20 = 26.67) 
(c), and a significant decrease in α3 isoform levels 3 days after SCI, with no difference between genotypes (two‑way ANOVA: time ****p < 0.0001, 
 F1,12 = 53.06) (d). Results, expressed as fold change in relation to naïve α2+/+ mice, are the mean ± SEM of 5 mice/group. ***p < 0.001, **p < 0.01, 
*p < 0.05, Bonferroni’s post hoc
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CD45 antigen (CD stands for cluster of differentiation; 
also know as leukocyte common antigen (LCA)) as a 
specific cell-surface markers for microglia/macrophages 
[33] 7  days after SCI [34]. Based on microscopic evalu-
ation, F4/80+ and  CD45+ cells located near the epi-
center displayed a macrophage-like morphology with 
large round cell bodies, whereas F4/80+ and  CD45+ cells 
located further away from the epicenter displayed a more 
microglial-like morphology with small cell bodies and 
numerous branched processes. No apparent difference 
in the distribution or density of either F4/80+ (Fig.  7a) 
or  CD45+ (Fig. 7b) cells between α2+/+ and α2+/G301R mice 
was observed. All together, these data suggest that micro-
glial and leukocyte activation and recruitment following 
SCI are not affected by reduced levels of the α2 isoform in 
the spinal cord.
Discussion
Using a knock-in mouse model with the loss-of-function 
disease-mutation G301R in the Atp1a2-gene encoding 
the astrocyte-specific α2-isoform of the  Na+/K+-ATPase 
[22, 35], we demonstrated that α2+/G301R mice displayed 
decreased lesion volume and improved functional out-
come 7  days after SCI, without altering the inflam-
matory response to SCI. The BMS and lesion volume 
were assessed 7 days after SCI, and evaluation at longer 
time points after SCI were not included. Moreover, 
Fig. 4 AQP4 protein levels in naïve and SCI‑treated α2
+/+ and α2
+/G301R mice. a AQP4 protein levels in naïve conditions and 3 days after SCI were 
evaluated in spinal cord lysates from α2
+/+ and α2
+/G301R mice by Western blot analysis (b). Data are normalized to GAPDH protein expression, with 
no difference between genotypes or treatment (Tukey’s multiple comparisons test, naïve α2
+/+ verus SCI‑treated α2
+/+, α2
+/G301R and naïve α2
+/G301R 
p = 0.96, p = 0.71 and p = 0.95, respectively, and SCI‑treated α2+/+ versus naïve and SCI‑treated α2+/G301R, p = 0.43 and p = 0.74, respectively, and 
naïve α2
+/G301R versus SCI‑treated α2
+/G301R, p = 0.94) (n = 4 animal/group). c Immunohistochemical staining for AQP4 was comparable between 
α2
+/+ and α2
+/G301R mice 3 days after SCI. Analysis was based on five sections from each animal, n = 4 mice/group. Scale bars low magnifica‑
tion = 200 μm; high magnification = 50 μm
Table 2 Quantification of AQP4 protein levels in the spinal 
cord in naïve and SCI-treated conditions
Data are presented as mean ± SEM, n = 4/group. Data are normalized to GAPDH 
protein
AQP4
Naïve SCI
α2
+/+ 1 ± 0.37 1.11 ± 0.46
α2
+/G301R 0.76 ± 0.11 0.89 ± 0.17
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the mechanisms underlying both acute and long term 
responses post SCI in the α2+/G301R mice remain to be 
addressed.
The α2+/G301R mice expressed reduced (~40%) α2 iso-
form levels in their spinal cords under naïve conditions. 
Interestingly, while both α1 and α3 isoform levels were 
Fig. 5 Chemokine expression profiling after SCI. a CXCL1 (two‑way ANOVA: time ***p < 0.001,  F1,12 = 28.75), b CLL2 (two‑way ANOVA: time 
****p < 0.0001,  F1,12 = 71.50), and c CCL5 (two‑way ANOVA: time ***p < 0.001,  F1,12 = 31.76) protein levels were quantified by multiplex tech‑
nology in naïve mice and 3 days after SCI in α2
+/G301R and α2
+/+ mice. For each protein, results are expressed as mean ± SEM, n = 4 mice/group. 
****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05, Bonferroni’s post hoc
Fig. 6 Cytokine expression profiling after SCI. a TNF (two‑way ANOVA: time **p < 0.01,  F1,12 = 16.1), b IL‑6 (two‑way ANOVA: time ****p < 0.0001, 
 F1,12 = 302.90), c IL‑10 (two‑way ANOVA: time ***p < 0.001,  F1,12 = 20.77), d IL‑1β (two‑way ANOVA: time **p < 0.01,  F1,12 = 11.45), and e IL‑5 protein 
levels were quantified by multiplex technology in naïve mice and 3 days after SCI in α2
+/G301R and α2
+/+ mice. For each protein, results are expressed 
as mean ± SEM, n = 4 mice/group. ****p < 0.0001, **p < 0.01, *p < 0.05, Bonferroni’s post hoc
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significantly altered in both genotypes following moder-
ate SCI, the α2 isoform was only significantly decreased 
in α2+/+ mice following SCI injury, whereas the α2 iso-
form level remained comparable between naïve and SCI-
injured tissues in the α2+/G301R mice. This might reflect the 
fact that there is a lower threshold for α2 isoform expres-
sion and cell survival in the α2+/G301R mice.
After moderate SCI injury, the recovery was evaluated 
by functional outcome, estimation of lesion volumes and 
changes in pro- and anti-inflammatory cytokines and 
potential changes in microglial/leukocyte activation. 
Interestingly, the functional recovery of the α2+/G301R mice 
was superior to α2+/+ mice and correlated with a signifi-
cantly reduced lesion size in the α2+/G301R compared to 
α2+/+ mice. In support of these findings, it was recently 
found that knock-down of the α2Na+/K+-ATPase in 
astrocytes deficient of the mutant superoxide dismutase 
1 (SOD1) was able to protect motor neurons from degen-
eration in co-cultured primary motor neurons [36]. 
Heterozygous in  vivo knock-down of the Atp1a2 gene 
by lentiviral-mediated RNAi in the spinal cord of SOD1 
mutant mice suppressed motor neuron degeneration and 
subsequently increased the life span of mutant SOD1 
mice [36]. Moreover, in SOD-deficient astrocytes, mito-
chondrial respiration and inflammatory gene expressions 
were induced, suggesting that the upregulation of the 
α2Na+/K+-ATPase upregulated mRNAs encoding mito-
chondrial respiration and expression of secreted inflam-
matory factors (Spp1, Lcn2, Clm1, Wnt1, Ccl11, Cxcl1, 
Ccr4, Il1Bbm, Itgb2, IIi1r1) in SOD1 mutant astrocytes.
We interrogated the possibility that AQP4 might be 
regulated differentially in α2+/G301R compared to α2+/+ 
mice. Overall, there was no difference in AQP4 level 
between the genotypes nor was there any significant dif-
ference between naïve and SCI-treated mice. Previous 
studies on cerebral edema found that reduced levels of 
AQP4 significantly improved the outcome [25, 26], which 
suggests that maybe the α2Na+/K+-ATPase works inde-
pendently of AQP4 in the area tested, or maybe the effect 
would be more evident in later stages after SCI, which 
awaits future testing.
We found that chemokines CXCL1, CCL2 and CCL5 
and cytokines TNF, IL-6 and IL-10 were significantly 
upregulated in the lesioned spinal cord of α2+/G301R and 
α2+/+ mice compared to naïve conditions, however, we 
observed no statistical differences between the two 
Fig. 7 Microglial and leukocyte immunoreactivity 7 days after SCI. Immunohistochemical staining for F4/80 (a) and CD45 (b) were comparable 
between α2
+/+ and α2
+/G301R mice 3 days after SCI. Analysis was based on 5 sections from each animal, n = 4 mice/group. Scale bars low magnifica‑
tion = 200 μm; high magnification = 50 μm
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genotypes. CCL2 [37], IL-6 [38, 39] and IL-10 [40] have 
previous been shown to be upregulated following SCI. 
Interstingly, there appeared to be a tendency towards 
genotype differences in the expression of CCL5 and IL-1β 
and future studies will be required to make a functional 
link between pump function and these two cytokines.
The pathophysiology of SCI involves a primary 
mechanical injury and a delayed secondary injury due to 
a number of proposed mechanisms including ischemia, 
abnormal intracellular shifts of ions including  Na+, and 
excitotoxic cell death. A reduction or defect to extrude 
 Na+ by the  Na+/K+-ATPase pump as a consequence of 
the mutation introduced will result in increased intra-
cellular  Na+ levels, which might increase even further 
following SCI. In fact, increased intracellular  Na+ con-
centration has been suggested to exacerbate the effects of 
compression trauma to the spinal cord in rats [41]. Fur-
thermore, the collapse of transmembrane  Na+ and  K+ 
gradients following SCI is expected to induce a reversed 
operation of the  Na+-dependent glutamate transporters, 
leading to glutamate efflux and subsequent activation of 
glutamate receptors causing substantial  Ca2+-dependent 
injury [42]. It has previously been shown that mature 
neuronal and astrocytic co-cultures from α2G301R/G301R 
mice display significantly reduced uptake of glutamate, 
and subsequently, increased glutamate levels [22]. It 
remains to be functionally tested if astrocytes in the spi-
nal cord of α2+/G301R mice will be altered.
The  Na+/K+-ATPase can also act as a signal transducer 
and a NF-κB activator by interacting with neighboring 
membrane proteins and organized cytosolic cascades of 
signaling proteins [27, 43]. The activity of the  Na+/K+-
ATPase is modulated by glutamate by NMDA receptor-
nitric oxide production, leading to activation of cyclic 
GMP-PKG [44, 45]. Interestingly, ouabain can induce a 
time- and dose-dependent activation of NF-κB and an 
upregulation of Tnf-α, Il-1β, and Bdnf mRNA levels [46].
Several other studies have correlated reduced  Na+/
K+-ATPase activity to SCI. A rat model of SCI induced 
by extradural compression of the cord resulted in a 50% 
decrease in the activity of synaptosomal  Na+/K+-ATPase 
30 min after the compression injury [47].
Conclusion
In conclusion, the α2+/G301R mice recover highly sig-
nificantly after SCI compared to littermate α2+/+ control 
mice tested 7 days after SCI. The molecular mechanisms 
regarding this rapid recovery as a consequence of less 
 Na+/K+-ATPase activity in astrocytes in relation to 
inflammatory responses remain to be elucidated, and 
these results serves as a proof of concept study and open 
promising potential towards therapeutic applications 
towards SCI.
Methods
Mice
Animals were housed in ventilated cages at a 12-h light/
dark cycle, under controlled temperature and humidity, 
and free access to food and water. Mice were cared for in 
accordance with the protocols and guidelines approved 
by The Danish Animal Inspectorate under the Ministry 
of Food and Agriculture, Denmark (J. No. 2013-15-2934-
00924 to KLL and J. No. 2013-15-2934-00815 to KLH); 
experiments performed in accordance with the ARRIVE 
guidelines, and all efforts were made to minimize pain 
and distress. All animal procedures were approved by 
Institutional Animal Care and Use Committee at the 
University of Aarhus and Southern Danish University, 
Denmark. All experiments were performed blinded.
Genotyping
Heterozygous α2+/G801R  mice [22] were genotyped by 
High Resolution Melt analysis (Roche  Lightcycler® 
96 Real-Time PCR System) using primers F-5′-
ggatgagggacagaacgaag and R-5′-catggagatcgagcatttca 
(Sigma-Aldrich).
Induction of spinal cord injury
A ketamine (100  mg/kg, VEDCO Inc)/xylazine (10  mg/
kg, VEDCO Inc) cocktail was used to anaesthetize mice, 
and mice were laminectomized between vertebrae T8 
and T10, and the impactor lowered at a pre-determined 
impact force resulting in an approximate displacement 
of 500 μm (moderate injury) [48]. Contusion injury was 
induced with the mouse Infinite Horizon-0400 SCI Con-
tusion Device (Precision Systems and Instrumentation, 
LLC). Following SCI, mice were sutured and injected 
with saline to prevent dehydration and buprenorphine 
hydrochloride (0.001  mg/20  g Temgesic) four times at 
8-h intervals, starting immediately prior to surgery. Indi-
vidually, mice recovery in single cages, where their post-
surgical health status was monitored during a 24–48  h 
recovery period, and then observed twice daily for activ-
ity level, respiratory rate and general physical condition. 
Manual bladder expression was performed twice a day 
and body weight was monitored. Mice received s.c. pro-
phylactic injections of antibiotic gentamicin (40  mg/kg) 
to prevent urinary tract infections. No mice died during 
experiments.
Functional outcome
Basso mouse scale
Functional post-SCI recovery of hind limb function was 
determined by scoring of the locomotor hindlimb per-
formance in the open field using the Basso Mouse Scale 
(BMS) system, a 0 to 9 rating system designed specifically 
for the mouse [48]. Under observer-blinded conditions, 
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mice were evaluated over a 4-min period 1, 3, and 7 days 
after SCI. Only mice with a score below 2 on day 1 
were included in the study. Mice were handled and pre-
trained in the open field before surgery to prevent fear 
and/or stress behaviors that could bias the locomotor 
assessment.
Tissue processing
Histopathology and immunohistochemistry
Mice were deeply anaesthetized using an overdose of 
pentobarbital (200 mg/ml) containing lidocaine (20 mg/
ml) and perfused through the left ventricle with cold 4% 
paraformaldehyde (PFA) in phosphate-buffered saline 
(PBS). Spinal cords were quickly removed and tissue seg-
ments containing the lesion area (1 cm centered on the 
lesion) were paraffin-embedded and cut into 10 parallel 
series of 15 μm thick microtome sections. Sections were 
stored at room temperature.
Klüver‑Barrera Luxol Fast Blue staining for myelinated fibers
For evaluation of lesion pathology, one series of sections 
from each animal was stained in Luxol Fast Blue (LFB) 
(0.1% LFB in 95% ethanol (EtOH) and 0.05% acetic acid) 
at 60  °C for 12  h. Sections were rinsed in 96% EtOH 
and distilled  H2O, immersed briefly in lithium carbon-
ate (0.05%  Li2CO3 in distilled water) and differentiated 
in 70% EtOH, before rinsed thoroughly in distilled  H2O 
and immersed in 0.05% lithium carbonate to stop further 
differentiation. Sections were submitted to hematoxy-
lin, rinsed in running tap water and immersed briefly in 
eosin solution. Finally, sections were rinsed in 70% EtOH, 
followed by 3× 99% EtOH, placed in 3× xylene prior to 
mounting with Depex. Paraffin embedded sections were 
deparaffinized 3× 3  min in xylene, 3× 2  min in 99% 
EtOH and 2× 2 min in 96% EtOH, before staining.
Immunohistochemical staining for CD45 and F4/80
Heat-induced antigen retrieval was done on the paraffin 
embedded sections by boiling the sections in Tris-EGTA 
buffer, pH 9.0 (CD45), TRS buffer (Target Retrieval Solu-
tion, DAKO) (F4/80), or TEG buffer, pH 9.0 (AQP4), first 
15 min at 900W, then 9 min at 440W. The sections were 
allowed to cool in the buffer before blocked for endog-
enous peroxidase and biotin activity. Sections were then 
incubated with anti-CD45 (1:100; clone 30-F11 (Ly 5); BD 
Pharmingen), anti-F4/80 (1:100, AbD Serotec), or anti-
AQP4 (1:1250; AQP-004, Alomone labs) antibodies and 
detected using biotinylated rabbit anti-rat IgG (DAKO) 
(CD45 and F4/80) or biotinylated donkey anti-rabbit 
IgG diluted 1:200 followed by ready-to-use anti-rabbit 
horse-radish perioxidase (HRP)-labelled polymer (EnVi-
sion + System, DAKO) with diaminobenzidin  (DAB+) as 
chromogen (DAKO). Nuclei were counterstained using 
Mayer’s haemalum w/4.5% chloralhydrate. As negative 
control, the primary antibody was omitted to check for 
any unspecific reaction from the detection system. As 
positive control for antibody-specificity, the staining was 
tested using a mouse multi block containing several dif-
ferent tissues including lymphatic organs. The activation 
state of  CD45+, and F4/80+ microglia and leukocytes and 
AQP4 expression were investigated in 5 sections (repre-
senting 750  μm spinal cord) from each animal centered 
on the lesion epicenter.
Immunofluorescent staining for glial fibrillary acidic protein 
(GFAP)
One series of sections from each animal was deparaffi-
nized and rehydrated by placing the sections 3× 3 min in 
xylene, 3× 2 min in 99% EtOH, 2× 2 min in 96% EtOH, 
2 min in 70% EtOH and finally 5 min in running tap water. 
The sections were demasked using TEG-buffer by placing 
the sections in warm TEG-buffer in a steamer for 15 min, 
then letting them cool for 15  min at room temperature 
before rinsing them for 15  min in running tap water. 
Sections were then rinsed 3× 15  min in tris-buffered 
saline (TBS) before they were pre-incubated with 10% 
fetal bovine serum (FBS) in TBS with 0.5% Triton X-100 
for 30  min. Sections were incubated with Alexa  Fluor® 
488-conjugated anti-GFAP (clone 131-17719, ThermoFis-
cher Scientific) diluted 1:400 for 1  h at room tempera-
ture and hereafter over night at 4  °C. Next day, sections 
were placed at room temperature for 30 min before they 
were rinsed in TBS for 10 min and then in TBS with 0.1% 
Triton X-100 for 10 min. The sections were then stained 
with  NeuroTrace® 530/615 Red Fluorescent Nissl Stain 
(ThermoFischer Scientific) for 20 min, and further rinsed 
2× 10  min in TBS before the sections were immersed 
in a TBS solution containing 10  μM diamidino-2-phe-
nylindole (DAPI) for 10  min. The sections were shortly 
rinsed in distilled water before they were mounted with 
ProLong Diamond. Control reactions were performed by 
omitting the primary antibody or by substituting the pri-
mary antibody with Alexa  Fluor® 488 conjugated mouse 
IgG1κ (ThermoFischer Scientific). Sections were devoid 
of staining in the FITC imaging filter.
Double immunofluorescent staining for the  a2 isoform 
and neuronal nuclei (NeuN)
Sections were prepared as desribed above for GFAP 
staining. Primary antibodies α2 (Merck Millipore) 
diluted 1:300 and NeuN (clone A60, Merck Millipore) 
diluted 1:300 [49] were applied in 1% donkey serum PBS 
with 0.02% Triton X-100 overnight at 4 °C. The following 
day, secondary labeling was perfomred with Alexa  Fluor® 
488-conjugated donkey anti-rabbit antibody and Alexa 
 Fluor® 568-conjugated streptavidin (Life Technologies) 
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diluted 1:350 in 1% donkey serum PBS with 0.025% 
Triton X-100 for 1  h at room temperature. Hoechst 
(1:10,000) (Life technologies) was used to counterstain 
the nuclei. Sections were then mounted with fluores-
cence mounting medium (Dako) and subsequently ana-
lysed on a LSM510 laser-scanning confocal microscope 
using a 40× C-Apochromat water immersion objective 
NA 1.2 (Carl Zeiss). Zen 2011 software (Carl Zeiss) was 
used for image capturing and analysis.
Lesion volume estimation
The volume of the injury was determined from the area of 
every tenth section sampled by systematic uniform ran-
dom sampling. Area of the lesion site was estimated as 
previously described [48]. Digital images were acquired 
using the 4× lens on an Olympus BX51 microscope fitted 
with an Olympus DP70 digital camera and a computer-
ized specimen stage (Prior, Multicontrol 2000 MW). The 
Image J software was used to calculate the area of the 
injury on each section. These areas were summarized and 
multiplied by the section distance, resulting in an esti-
mate of the total volume after dehydration and paraffin 
embedding.
Western blotting
Whole spinal cord protein samples from α2+/G301R and 
α2+/+ littermate mice exposed to SCI and allowed 3 days 
survival in addition to naïve α2+/G301R and α2+/+ littermate 
mice were prepared as described [50]. Equal amounts of 
protein were separated by SDS-PAGE on 10–14% (α1, α2, 
α3 and AQP4) gels and electro-blotted onto nitrocellulose 
membranes (Pharmacia-Amersham). Membranes were 
blocked in PBS with 5% skimmed milk and 0.5% Tween-
20 and incubated with the following primary antibod-
ies: anti-α1 diluted 1:2000 (clone a6f-c, Developmenal 
Studies Hybridoma Bank), anti-α2 diluted 1:1000 (Merck 
Millipore), anti-α3 diluted 1:1000 (Merck Millipore), anti-
AQP4 diluted 1:1000 (AQP-004, Alomone labs) anti-
GAPDH diluted 1:1000 (Abcam), or anti-β-Actin diluted 
1:2000 (Sigma-Aldrich) overnight at 4 °C.
Next, membranes were incubated with HRP-con-
jugated secondary antibodies (swine anti-rabbit HRP 
diluted 1:2000 (Dako) or rabbit anti-mouse HRP diluted 
1:2000 (Dako)) for 1  h at room temperature. Visualiza-
tion of blots was done in a LAS 3000 imager (Fujifilm) 
with Amersham ECL Western Blotting Detection Kit (GE 
Healthcare). Post densitometric analysis and image pro-
cessing of blots were performed in Image J.
Multiplex analysis
To measure cytokine protein levels by the MSD Mouse 
Proinflammatory V-Plex Plus Kit (IFNγ, IL-1β, IL-2, IL-4, 
IL-5, IL-6, IL-10, IL-12p70, CXCL1, TNF; K15012C, 
Mesoscale) under naïve conditions and 3 days after SCI, 
we used a SECTOR Imager 6000 (Mesoscale Discovery, 
Rockville, USA) Plate Reader according to the manu-
facturer’s instructions. The same samples as those used 
for Western blotting were diluted two-fold in Diluent 
41 prior to measurement and 50  µl dilution was loaded 
in each well. Data was analyzed using MSD Discovery 
Workbench software [50, 51].
Statistical analysis
Comparisons were performed using repeated measures 
(RM) or regular two-way ANOVA followed by multiple t 
test analysis or Bonferroni post hoc, or by Student’s t test. 
Analyses were performed using Prism 4.0b software for 
Macintosh, (GraphPad Software). Statistical significance 
was established for p < 0.05.
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